Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden
NCT ID: NCT04382417
Last Updated: 2021-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
57 participants
OBSERVATIONAL
2020-03-26
2020-11-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality
NCT04390074
Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19
NCT04462393
Factors Associated With Decisions to Withhold or Withdraw Intensive Care
NCT05394961
Long Term Outcome in ICU Treated COVID-19: Risk Factors for 1-year Mortality
NCT05063747
Mechanisms for Organ Dysfunction in Covid-19
NCT04316884
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Covid-19
Patients with verified or highly suggestive Covid-19 diagnosis and Intensive Care treatment.
Observational study
Not required
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational study
Not required
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients admitted to the Intensive Care Unit with one or more negative tests but with clinical and radiological characteristics highly suggestive of SARS-CoV-2 and thus considered positive for the disease.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Västmanland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erland Ostberg
M.D., Ph.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erland Östberg, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Region Västmanland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Intensive Care Unit, Västerås Hospital
Västerås, Västmanland County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RegionVastmanland
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.